Related Experiment Video
Updated: May 9, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Celastrol inhibits TGF-β1-induced epithelial-mesenchymal transition by inhibiting Snail and regulating E-cadherin
Hyereen Kang1, Minjae Lee, Sung-Wuk Jang
1Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract:
The epithelial-mesenchymal transition (EMT) is a pivotal event in the invasive and metastatic potentials of cancer progression. Celastrol inhibits the proliferation of a variety of tumor cells including leukemia, glioma, prostate, and breast cancer; however, the possible role of celastrol in the EMT is unclear. We investigated the effect of celastrol on the EMT. Transforming growth factor-beta 1 (TGF-β1) induced EMT-like morphologic changes and upregulation of Snail expression. The downregulation of E-cadherin expression and upregulation of Snail in Madin-Darby Canine Kidney (MDCK) and A549 cell lines show that TGF-β1-mediated the EMT in epithelial cells; however, celastrol markedly inhibited TGF-β1-induced morphologic changes, Snail upregulation, and E-cadherin expression. Migration and invasion assays revealed that celastrol completely inhibited TGF-β1-mediated cellular migration in both cell lines. These findings indicate that celastrol downregulates Snail expression, thereby inhibiting TGF-β1-induced EMT in MDCK and A549 cells. Thus, our findings provide new evidence that celastrol suppresses lung cancer invasion and migration by inhibiting TGF-β1-induced EMT.
Insights
Celastrol inhibits cancer cell migration and invasion by blocking the epithelial-mesenchymal transition (EMT). This compound suppresses key EMT markers, offering a potential therapeutic strategy for advanced cancers.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- The epithelial-mesenchymal transition (EMT) is crucial for cancer cell invasion and metastasis.
- Celastrol is known to inhibit tumor cell proliferation, but its role in EMT was unexplored.
Purpose of the Study:
- To investigate the effect of celastrol on TGF-β1-induced EMT.
- To determine if celastrol can inhibit cancer cell migration and invasion by targeting EMT.
Main Methods:
- Utilized Madin-Darby Canine Kidney (MDCK) and A549 cell lines to study EMT.
- Administered transforming growth factor-beta 1 (TGF-β1) to induce EMT.
- Assessed changes in cell morphology, E-cadherin and Snail expression, and cell migration/invasion.
Main Results:
- TGF-β1 induced EMT-like changes, including Snail upregulation and E-cadherin downregulation.
- Celastrol significantly inhibited TGF-β1-induced morphological changes and Snail upregulation.
- Celastrol completely blocked TGF-β1-mediated cell migration and invasion, and restored E-cadherin expression.
Conclusions:
- Celastrol effectively inhibits TGF-β1-induced EMT in epithelial cells.
- Celastrol suppresses cancer cell invasion and migration by downregulating Snail expression.
- Celastrol demonstrates potential as an anti-metastatic agent in lung cancer treatment.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Specific Gene Expression

